{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:18:32Z","timestamp":1795043912709,"version":"4.10.2"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>\n                    Primary cutaneous acral CD8\n                    <jats:sup>+<\/jats:sup>\n                    T-cell lymphoproliferative disorder has been recognized by the World Health Organization as a distinct entity characterized by dermal-based, nonulcerated nodules typically involving the auricle and following an indolent course. By contrast, cytotoxic cutaneous lymphomas presenting with tumoral lesions of the auricle can follow a locally aggressive or metastatic course. In this study, we discuss the presentation, diagnosis, molecular characteristics, and treatment options for these under-recognized, aggressive cytotoxic lymphomas of the auricle. Six cases of cytotoxic lymphoma NOS and 4 cases of CD4\n                    <jats:sup>+<\/jats:sup>\n                    primary cutaneous \u03b3\u03b4 T-cell lymphoma that presented as auricular tumors were included in this series. Patches at other sites resembling mycosis fungoides with variable immunophenotypes were observed in 7 cases. Despite multimodal therapy, 7 of 10 patients died within median 14 months of presentation. Necrotizing and locally progressive tumors of the auricle may represent an ominous sign of aggressive treatment-refractory cytotoxic lymphomas characterized by swift mortality.\n                  <\/jats:p>","DOI":"10.1097\/dad.0000000000003433","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:09Z","timestamp":1789516809000},"page":"955-962","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Aggressive Cytotoxic Lymphomas of the Auricle: An Under-recognized Presentation"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1334-5342","authenticated-orcid":false,"given":"Madeline J.","family":"Hooper","sequence":"first","affiliation":[{"name":"Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa M.","family":"LeWitt","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Indiana University, Indianapolis, IN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Aguilar","family":"Neuville","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Bohjanen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Giubellino","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Garcia-Herrera","sequence":"additional","affiliation":[{"name":"Hematopathology Unit, Department of Pathology, Hospital Cl\u00ednic, Universitat de Barcelona, Instituto de Investigaciones Biom\u00e9dicas August Pi i Sunyer, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Estrach","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital Cl\u00ednic, Universitat de Barcelona, Instituto de Investigaciones Biom\u00e9dicas August Pi i Sunyer, Barcelona, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Querfeld","sequence":"additional","affiliation":[{"name":"Division of Dermatology and Department of Pathology, City of Hope National Medical Center, Duarte, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong A.","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[{"name":"Hematopathology Unit, Department of Pathology, Hospital Cl\u00ednic, Universitat de Barcelona, Instituto de Investigaciones Biom\u00e9dicas August Pi i Sunyer, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Guitart","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"R1-20261118","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"R2-20261118","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/cup.12633","article-title":"Indolent CD8-positive lymphoid proliferation of acral sites: three further cases of a rare entity and an update on a unique patient","volume":"43","author":"Kluk","year":"2016","journal-title":"J Cutan Pathol."},{"key":"R4-20261118","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/cup.13020","article-title":"Primary cutaneous acral CD8 positive T-cell lymphoma with extra-cutaneous involvement: a long-standing case with an unexpected progression","volume":"44","author":"Alberti-Violetti","year":"2017","journal-title":"J Cutan Pathol."},{"key":"R5-20261118","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bjd.20973","article-title":"Clinical, histopathological and prognostic features of primary cutaneous acral CD8+ T-cell lymphoma and other dermal CD8+ cutaneous lymphoproliferations - results of an EORTC Cutaneous Lymphoma Group Workshop","volume":"186","author":"Kempf","year":"2022","journal-title":"Br J Dermatol."},{"key":"R6-20261118","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/DAD.0b013e3182a74c7a","article-title":"Multicenter case series of indolent small\/medium-sized CD8+ lymphoid proliferations with predilection for the ear and face","volume":"36","author":"Li","year":"2014","journal-title":"Am J Dermatopathol."},{"key":"R7-20261118","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/cup.12045","article-title":"Indolent CD8+ lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features","volume":"40","author":"Greenblatt","year":"2013","journal-title":"J Cutan Pathol."},{"key":"R8-20261118","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/bjd.13628","article-title":"CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas","volume":"172","author":"Wobser","year":"2015","journal-title":"Br J Dermatol."},{"key":"R9-20261118","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)65144-9","article-title":"Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior","volume":"155","author":"Berti","year":"1999","journal-title":"Am J Pathol."},{"key":"R10-20261118","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/modpathol.2016.240","article-title":"Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas","volume":"30","author":"Guitart","year":"2017","journal-title":"Mod Pathol."},{"key":"R11-20261118","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1182\/blood.2021012536","article-title":"Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway","volume":"138","author":"Lee","year":"2021","journal-title":"Blood"},{"key":"R12-20261118","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"R13-20261118","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/modpathol.2009.196","article-title":"CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma","volume":"23","author":"Laharanne","year":"2010","journal-title":"Mod Pathol."},{"key":"R14-20261118","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.3324\/haematol.2024.285233","article-title":"Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations","volume":"109","author":"Myers","year":"2024","journal-title":"Haematologica"},{"key":"R15-20261118","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41467-020-15572-7","article-title":"Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas","volume":"11","author":"Daniels","year":"2020","journal-title":"Nat Commun."},{"key":"R16-20261118","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/DAD.0000000000001366","article-title":"Primary cutaneous acral CD8+ T-cell lymphoma-a single center review of 3 cases and recent literature review","volume":"41","author":"Tjahjono","year":"2019","journal-title":"Am J Dermatopathol."},{"key":"R17-20261118","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/cup.13517","article-title":"Primary cutaneous acral CD8+ T\u2010cell lymphoma of the ear: a case report","volume":"46","author":"Ormerod","year":"2019","journal-title":"J Cutan Pathol."},{"key":"R18-20261118","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/bjh.15572","article-title":"Primary cutaneous acral CD8+ T-cell lymphomas relapse more frequently in younger patients","volume":"185","author":"Maubec","year":"2019","journal-title":"Br J Haematol."},{"key":"R19-20261118","doi-asserted-by":"crossref","first-page":"20363613231204046","DOI":"10.1177\/20363613231204046","article-title":"The enigmatic ear: unveiling a rare case of a primary cutaneous CD8+ acral T-cell lymphoproliferative disorder with a literature review","volume":"15","author":"Sahraoui","year":"2023","journal-title":"Rare Tumors"},{"key":"R20-20261118","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/PAS.0b013e318068b527","article-title":"Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?","volume":"31","author":"Petrella","year":"2007","journal-title":"Am J Surg Pathol."},{"key":"R21-20261118","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0560.2009.01278.x","article-title":"Indolent CD8+ lymphoid proliferation of the ear: a phenotypic variant of the small-medium pleomorphic cutaneous T-cell lymphoma?","volume":"37","author":"Beltraminelli","year":"2010","journal-title":"J Cutan Pathol."},{"key":"R22-20261118","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1600-0560.2012.01917.x","article-title":"Indolent CD8-positive T-cell lymphoid proliferation of the ear: a report of two cases","volume":"39","author":"Zeng","year":"2012","journal-title":"J Cutan Pathol."},{"key":"R23-20261118","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/cup.14095","article-title":"Indolent CD8+ primary cutaneous T-cell lymphoma involving the eyelid of an adolescent","volume":"48","author":"Minzenmayer","year":"2021","journal-title":"J Cutan Pathol."},{"key":"R24-20261118","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ijd.13340","article-title":"Long-term follow-up and management of small and medium-sized CD4+ T cell lymphoma and CD8+ lymphoid proliferations of acral sites: a multicenter experience","volume":"55","author":"Virmani","year":"2016","journal-title":"Int J Dermatol."},{"key":"R25-20261118","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.clindermatol.2023.09.002","article-title":"Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder: a clinical and histologic retrospective cohort study","volume":"41","author":"Stephan","year":"2023","journal-title":"Clin Dermatol."},{"key":"R26-20261118","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/DAD.0b013e318297f7fd","article-title":"Indolent CD8+ lymphoid proliferation of the face with eyelid involvement","volume":"36","author":"Hagen","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"R27-20261118","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/cup.14026","article-title":"Immunophenotypic switch in cutaneous T\u2010cell lymphoma: a series of three cases and review of the literature","volume":"48","author":"Bitar","year":"2021","journal-title":"J Cutan Pathol."},{"key":"R28-20261118","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/PAS.0000000000000786","article-title":"Immunophenotypic shifts in primary cutaneous \u03b3\u03b4 T-cell lymphoma suggest antigenic modulation: a study of sequential biopsy specimens","volume":"41","author":"Agbay","year":"2017","journal-title":"Am J Surg Pathol."},{"key":"R29-20261118","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/PAS.0b013e31826a5038","article-title":"Cutaneous \u03b3\u03b4 T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas","volume":"36","author":"Guitart","year":"2012","journal-title":"Am J Surg Pathol."},{"key":"R30-20261118","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/annonc\/mdf293","article-title":"Gamma delta T-cell neoplasms: a clinicopathological study of 11 cases","volume":"13","author":"Saito","year":"2002","journal-title":"Ann Oncol."},{"key":"R31-20261118","doi-asserted-by":"crossref","first-page":"e180417","DOI":"10.1172\/JCI180417","article-title":"Addiction of primary cutaneous \u03b3\u03b4 T cell lymphomas to JAK\/STAT signaling","volume":"135","author":"Zhang","year":"2025","journal-title":"J Clin Invest."},{"issue":"suppl ment_1","key":"R32-20261118","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/blood-2019-123986","article-title":"A phase 2 study of the dual SYK\/JAK inhibitor cerdulatinib demonstrates good tolerability and clinical response in relapsed\/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma","volume":"134","author":"Horwitz","year":"2019","journal-title":"Blood"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:00:22Z","timestamp":1795042822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003433","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]}}}